PSNL — Personalis, Inc.

Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Market Cap

$582.6M

P/E Ratio

-7.45

Beta

2.11

52-Week Range

2.826-11.5

Dividend Yield

$0.00

CEO

Christopher Hall

Employees

228

IPO Date

Jun 20, 2019

Exchange

NASDAQ